LAX-Support Formula
Natural health product licensed in Canada
- Licence holder
- Relife Wellness Ltd.
- NPN or DIN-HM
- 80149052
- Status
- Active licence
- Licence date
- 26 May 2026
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Frangula purshiana Cooper: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Senna alexandrina Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Rheum officinale Baill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Frangula purshiana Source : Frangula purshiana - Écorce âgée | 170 mg | Not calculated |
| Frangula alnus | 110 mg | Not calculated |
| Senna alexandrina | 70 mg | Not calculated |
| Senna alexandrina Potency : 20 % Sennosides | 25 mg | Not calculated |
| Rheum officinale Source : Rheum officinale - Racine et rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 50 mg | 10 mg | Not calculated |
| Taraxacum officinale Source : Taraxacum officinale - Feuille | 25 mg | Not calculated |
| Taraxacum officinale Source : Taraxacum officinale - Racine | 25 mg | Not calculated |
| Malva sylvestris Extraction ratio : 5:1 Dry plant equivalent : 25 mg | 5 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce | 20 mg | Not calculated |
| Glycyrrhiza glabra | 10 mg | Not calculated |
| Syzygium aromaticum Source : Syzygium aromaticum - Bourgeon floral | 10 mg | Not calculated |
| Gentiana lutea | 10 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Silice, Hydroxypropyl méthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Used in Herbal Medicine for the) short-term relief of occasional constipation. (Used in Herbal Medicine to) promote(s) bowel movement (by direct action on the large intestine). Cascara is (Traditionally) used in Herbal Medicine as a stimulant laxative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80149052
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.